Bailard, Inc. Curis Inc Transaction History

Bailard, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$4.45 - $8.09 $1.04 Million - $1.88 Million	-233,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.94 - $8.85 $1.34 Million - $1.71 Million	193,000 Added 482.5%	233,000 $1.82 Million
Q2 2021 Aug 13, 2021	BUY	$7.45 - $16.27 $298,000 - $650,800	40,000 New	40,000 $323,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.